Arkema Boosts Adhesives with China Buy

Arkema is buying Shanghai Zhiguan Polymer Materials (PMP), a Chinese company that specializes in reactive hot-melt polyurethane (HMPUR) adhesives for the consumer electronics market. Financial terms of the deal, which is scheduled to close this quarter, were not disclosed.

PMP’s adhesives are used in the bonding of mobile phones, tablets, laptops and connected objects. The Shanghai-based firm generates more than €1 million in annual sales.

Arkema said the acquisition is in line with the strategy of its adhesive solutions arm Bostik to build a strong position in the attractive engineering adhesives market and to accelerate development in the fast-growing electronics market, especially in Asia.

With PMP’s “solid positions” in the consumer electronics market, Bostik will strengthen its portfolio of technologies in engineering adhesives, where the group said it already has robust know-how in cyanoacrylate, methyl methacrylate (MMA) and UV technologies, developed through the acquisitions of Afinitica and Nitta in 2018 and AEC Polymers in 2013.

Arkema said the bolt-on acquisition has strong complementary technological and commercial assets, offering many development synergies that will contribute to substantially accelerating Bostik’s expansion in the Asian consumer electronics industry.

Also in China, Arkema last month upped its fluoropolymer expansion plans because of strong demand for lithium-ion batteries. It will now increase PVDF output by 50% instead of 35%, accelerating its development in the country’s battery business, as well as supporting significant growth in the water filtration, specialty coatings and semiconductor sectors.

Author: Elaine Burridge, Freelance Journalist

(c) Arkema
(c) Arkema

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.